Longboard Pharmaceuticals Inc (LBPH)
59.66
+0.15
(+0.25%)
USD |
NASDAQ |
Nov 05, 16:00
59.66
0.00 (0.00%)
After-Hours: 20:00
Longboard Pharmaceuticals Enterprise Value: 2.010B for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 2.010B |
| November 01, 2024 | 2.017B |
| October 31, 2024 | 2.018B |
| October 30, 2024 | 2.017B |
| October 29, 2024 | 2.012B |
| October 28, 2024 | 2.017B |
| October 25, 2024 | 2.014B |
| October 24, 2024 | 2.012B |
| October 23, 2024 | 2.012B |
| October 22, 2024 | 2.006B |
| October 21, 2024 | 2.003B |
| October 18, 2024 | 1.998B |
| October 17, 2024 | 1.997B |
| October 16, 2024 | 2.006B |
| October 15, 2024 | 1.993B |
| October 14, 2024 | 1.990B |
| October 11, 2024 | 1.208B |
| October 10, 2024 | 1.032B |
| October 09, 2024 | 992.81M |
| October 08, 2024 | 1.003B |
| October 07, 2024 | 992.43M |
| October 04, 2024 | 1.104B |
| October 03, 2024 | 1.097B |
| October 02, 2024 | 1.112B |
| October 01, 2024 | 1.138B |
| Date | Value |
|---|---|
| September 30, 2024 | 991.65M |
| September 27, 2024 | 939.91M |
| September 26, 2024 | 908.79M |
| September 25, 2024 | 911.13M |
| September 24, 2024 | 965.58M |
| September 23, 2024 | 975.31M |
| September 20, 2024 | 1.013B |
| September 19, 2024 | 994.37M |
| September 18, 2024 | 835.27M |
| September 17, 2024 | 767.98M |
| September 16, 2024 | 890.90M |
| September 13, 2024 | 1.030B |
| September 12, 2024 | 989.31M |
| September 11, 2024 | 1.002B |
| September 10, 2024 | 1.069B |
| September 09, 2024 | 1.038B |
| September 06, 2024 | 1.051B |
| September 05, 2024 | 1.013B |
| September 04, 2024 | 1.072B |
| September 03, 2024 | 1.018B |
| August 30, 2024 | 1.099B |
| August 29, 2024 | 1.078B |
| August 28, 2024 | 1.060B |
| August 27, 2024 | 1.064B |
| August 26, 2024 | 1.145B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-45.17M
Minimum
Jun 24 2022
2.018B
Maximum
Oct 31 2024
218.64M
Average
41.80M
Median
Nov 22 2023
Enterprise Value Benchmarks
| Johnson & Johnson | 396.44B |
| UnitedHealth Group Inc | 564.10B |
| Vanda Pharmaceuticals Inc | -104.97M |
| Edgewise Therapeutics Inc | 2.722B |
| Jasper Therapeutics Inc | 224.74M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.78M |
| Total Expenses (Quarterly) | 25.64M |
| EPS Diluted (Quarterly) | -0.56 |
| Earnings Yield | -3.60% |